{"id":915,"date":"2025-05-15T01:41:21","date_gmt":"2025-05-15T08:41:21","guid":{"rendered":"https:\/\/cloudbreakpharma.com\/?p=915"},"modified":"2025-05-15T02:08:43","modified_gmt":"2025-05-15T09:08:43","slug":"cloudbreak-pharma-inc-s-cbt-004-indicated-for-the-treatment-of-vascularised-pinguecula-has-completed-phase-ii-clinical-trials-in-the-united-states","status":"publish","type":"post","link":"https:\/\/cloudbreakpharma.com\/zh_hk\/cloudbreak-pharma-inc-s-cbt-004-indicated-for-the-treatment-of-vascularised-pinguecula-has-completed-phase-ii-clinical-trials-in-the-united-states\/","title":{"rendered":"\u64a5\u5eb7\u8996\u96f2\u6cbb\u7642\u8840\u7ba1\u5316\u77bc\u88c2\u6591\u5275\u65b0\u85e5CBT-004\u5728\u7f8e\u570b\u5b8c\u6210\u81e8\u5e8aII\u671f\u5be6\u9a57"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u64a5\u5eb7\u8996\u96f2\u6cbb\u7642\u8840\u7ba1\u5316\u77bc\u88c2\u6591\u5275\u65b0\u85e5CBT-004\u5728\u7f8e\u570b\u5b8c\u6210\u81e8\u5e8aII\u671f\u5be6\u9a57<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u773c\u79d1\u5275\u65b0\u85e5\u4f01\u64a5\u5eb7\u8996\u96f2 \uff08Cloudbreak Pharma Inc.\uff09\u7ba1\u7dda\u4e2d\u7528\u65bc\u6cbb\u7642\u8840\u7ba1\u5316\u77bc\u88c2\u6591\uff08\u53c8\u7a31\u5145\u8840\u6027\u7d50\u819c\u9ec3\u6591\uff09\u7684CBT-004\u65bc4\u6708\u5728\u7f8e\u570b\u5b8c\u6210\u81e8\u5e8aII\u671f\u5be6\u9a57\u3002\u521d\u6b65\u7d50\u679c\u986f\u793a\u773c\u90e8\u5b89\u5168\u6027\u512a\u7570\uff0c\u6709\u6548\u6027\u7684\u4e3b\u8981\u7d42\u9ede\u9054\u5230\u8a2d\u8a08\u8981\u6c42\uff0c\u591a\u9805\u6b21\u8981\u7d42\u9ede\u4e5f\u9054\u5230\u8a2d\u8a08\u8981\u6c42\u3002<\/span><\/p>

\u64a5\u5eb7\u8996\u96f2\u662f\u4e00\u5bb6\u5275\u65b0\u9a45\u52d5\u7684\u81e8\u5e8a\u773c\u79d1\u751f\u7269\u6280\u8853\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u958b\u767c\u5275\u65b0\u6027\u53ca\u5dee\u7570\u5316\u7642\u6cd5\u3002\u64a5\u5eb7\u8996\u96f2\u65bc2015\u5e74\u5728\u7f8e\u570b\u6210\u7acb\uff0c\u9664\u8a2d\u7acb\u5728\u52a0\u5dde\u723e\u7063\u7684\u7e3d\u90e8\u5916\uff0c\u5728\u4e2d\u570b\u5927\u9678\u548c\u4e2d\u570b\u9999\u6e2f\u4e5f\u6709\u5efa\u7acb\u904b\u71df\u6a5f\u69cb\u516c\u53f8\u81f4\u529b\u65bc\u81ea\u4e3b\u958b\u767c\u548c\u5546\u696d\u5316\u570b\u969b\u9996\u5275\u6216\u8005\u540c\u985e\u4e2d\u6700\u4f73\u7684\u773c\u79d1\u65b0\u85e5\uff0c\u4ee5\u89e3\u6c7a\u672a\u6eff\u8db3\u7684\u91ab\u7642\u9700\u6c42\u3002\u64a5\u5eb7\u8996\u96f2\u5df2\u5efa\u7acb\u4e86\u5ee3\u6cdb\u4e14\u5275\u65b0\u7684\u7ba1\u7dda\u5305\u62ec\u516b\u7a2e\u85e5\u7269\u5019\u9078\u7269\uff0c\u6db5\u84cb\u773c\u7403\u524d\u5f8c\u90e8\u7684\u4e3b\u8981\u75be\u75c5\uff0c\u5176\u4e2d\u56db\u6b3e\u8655\u65bc\u81e8\u5e8a\u968e\u6bb5\uff0c\u56db\u6b3e\u8655\u65bc\u81e8\u5e8a\u524d\u968e\u6bb5\u3002<\/span><\/p>

CBT-004\u662f\u4e00\u7a2e\u5c40\u90e8\u6ef4\u773c\u6db2\uff0c\u63a1\u7528\u591a\u6fc0\u9176\u6291\u5236\u5291\uff0c\u9776\u5411\u8840\u7ba1\u5167\u76ae\u751f\u9577\u56e0\u6578\u53d7\u9ad4\u53ca\u8840\u5c0f\u677f\u884d\u751f\u751f\u9577\u56e0\u6578\u53d7\u9ad4\uff0c <\/span>\u9069\u7528\u65bc\u6cbb\u7642\u8840\u7ba1\u5316\u77bc\u88c2\u6591\u3002<\/span><\/p>

\u77bc\u88c2\u6591\u662f\u4e00\u7a2e\u5713\u5f62\u3001\u6de1\u9ec3\u8272\u7684\u9686\u8d77\u7d44\u7e54\uff0c\u9577\u5728\u89d2\u819c\u9644\u8fd1\u7684\u7d50\u819c\u4e0a\u3002\u4e00\u822c\u800c\u8a00\uff0c\u7121\u75c7\u72c0\u7684\u77bc\u88c2\u6591\u7121\u9700\u6cbb\u7642\uff0c\u4f46\u5176\u6de1\u9ec3\u8272\u548c\u9686\u8d77\u7684\u8f2a\u5ed3\u53ef\u80fd\u6703\u5f15\u8d77\u6a5f\u68b0\u6027\u6216\u8207\u6dda\u819c\u4e0d\u826f\u6709\u95dc\u7684\u773c\u8868\u523a\u6fc0\u3002\u7d2b\u5916\u7dda\u7684\u7d2f\u7a4d\u7167\u5c04\u662f\u5c0e\u81f4\u77bc\u88c2\u6591\u7684\u4e3b\u8981\u539f\u56e0\uff0c\u7576\u75c5\u8b8a\u90e8\u4f4d\u51fa\u73fe\u8840\u7ba1\u5316\u6216\u767c\u708e\u6642\uff0c\u53ef\u80fd\u6703\u5c0e\u81f4\u773c\u90e8\u5145\u8840\u3001\u4e0d\u9069\u3001\u75bc\u75db\u3001\u7570\u7269\u611f\u3001\u6d41\u6dda\u548c\u75d5\u7662\u7b49\u75c7\u72c0\u3002\u76ee\u524d\u4e26\u7121\u7372\u7f8e\u570b\u85e5\u7ba1\u5c40\u6279\u51c6\u9069\u7528\u65bc\u8840\u7ba1\u5316\u77bc\u88c2\u6591\u7684\u85e5\u7269\u7642\u6cd5\u3002<\/span><\/p>

CBT-004\u65bc2023\u5e749\u6708\u905e\u4ea4\u7f8e\u570b\u85e5\u76e3\u5c40\u7533\u8acb\u4e26\u7372\u6279\u9032\u884c\u6cbb\u7642\u8840\u7ba1\u5316\u77bc\u88c2\u6591\u7684\u81e8\u5e8aII\u671f\u7814\u7a76\u3002\u6b64\u9805\u81e8\u5e8a\u5be6\u9a57\u5df2\u65bc2025\u5e744\u6708\u5728\u7f8e\u570b\u5b8c\u6210\u3002\u521d\u6b65\u8cc7\u6599\u5206\u6790\u986f\u793aCBT-004\u773c\u90e8\u5b89\u5168\u6027\u512a\u7570\u3002\u6b64\u9805\u7814\u7a76\u7684\u81e8\u5e8a\u6709\u6548\u6027\u4e3b\u8981\u7d42\u9ede\u70ba\u773c\u90e8\u7d50\u819c\u7d05\u816b\u3002\u6b64\u9805\u6307\u6a19\u9054\u5230\u4e86\u9810\u671f\u7d50\u679c\u3002\u5169\u7d44CBT-004\u7528\u85e5\u7d44\u8207\u5b89\u6170\u5291\u7d44\u76f8\u6bd4\uff0c\u7d50\u819c\u7d05\u816b\u5206\u6578\u90fd\u6709\u986f\u8457\u4e0b\u964d\uff0c\u4e26\u9054\u5230\u7d71\u8a08\u5b78\u5dee\u7570\u3002\u65bc\u6b64\u540c\u6642\uff0c\u5291\u91cf\u6548\u679c\u7684\u76f8\u95dc\u8cc7\u6599\u986f\u793a\uff0c\u9ad8\u5291\u91cf\u7d44\u512a\u65bc\u4f4e\u5291\u91cf\u7d44\u3002\u6b64\u5916\uff0c\u591a\u9805\u6709\u6548\u6027\u6b21\u8981\u6307\u6a19\uff0c\u7528\u85e5\u7d44\u548c\u5b89\u6170\u5291\u7d44\u5c0d\u6bd4\u4e5f\u9054\u5230\u7d71\u8a08\u5b78\u5dee\u5225\uff0c\u6709\u986f\u8457\u81e8\u5e8a\u6548\u679c\u3002CBT-004\u4f5c\u70ba\u4e00\u7a2e\u5c0f\u5206\u5b50\u591a\u6fc0\u9176\u6291\u5236\u5291\uff0c\u5728\u975e\u81e8\u5e8a\u85e5\u6548\u52d5\u7269\u6a21\u578b\u4ee5\u53ca\u52d5\u7269\u6bd2\u7406\u5be6\u9a57\u4e2d\u5747\u986f\u793a\u51fa\u826f\u597d\u7684\u6709\u6548\u6027\u548c\u5b89\u5168\u6027\u3002<\/span><\/p>

\u6839\u64da\u5f17\u82e5\u65af\u7279\u6c99\u5229\u6587\u5831\u544a\uff0c\u51682023\u5e74\u7684\u8840\u7ba1\u5316\u77bc\u88c2\u6591\u60a3\u8005\u4eba\u53e3\u70ba11.61\u5104\u4eba\uff0c\u5176\u4e2d\u7f8e\u570b\u65bc2023\u5e74\u7684\u8840\u7ba1\u5316\u77bc\u88c2\u6591\u60a3\u8005\u4eba\u53e3\u70ba4570\u842c\u4eba\uff0c\u800c\u4e2d\u570b\u65bc2023\u5e74\u7684\u8840\u7ba1\u5316\u77bc\u88c2\u6591\u60a3\u8005\u4eba\u53e3\u70ba2070\u842c\u4eba\u3002<\/span> \u8840\u7ba1\u5316\u77bc\u88c2\u6591\u85e5\u7269\u7684\u5168\u7403\u5e02\u5834\u898f\u6a21\u9810\u671f\u5c07\u65bc2033\u5e74\u9054\u52301.5393\u5104\u7f8e\u5143\u3002\u8840\u7ba1\u5316\u77bc\u88c2\u6591\u85e5\u7269\u7684\u7f8e\u570b\u53ca\u4e2d\u570b\u5e02\u5834\u898f\u6a21\u9810\u671f\u5c07\u65bc2033\u5e74\u5206\u5225\u9054\u52309.406\u5104\u7f8e\u5143\u53ca9220\u842c\u7f8e\u5143\u3002<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Cloudbreak Pharma Inc.’s CBT-004 indicated for the treatment of vascularised pinguecula has completed Phase II clinical trials in the United States Cloudbreak Pharma Inc. has completed the Phase II clinical trial investigating CBT-004 for the treatment of vascularized pinguecula in the United States in April. Preliminary results demonstrated excellent ocular and systemic safety profile. The […]<\/p>\n","protected":false},"author":16,"featured_media":736,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-915","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/posts\/915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/comments?post=915"}],"version-history":[{"count":0,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/posts\/915\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/media\/736"}],"wp:attachment":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/media?parent=915"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/categories?post=915"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/tags?post=915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}